A signaling mechanism for growth-related expression of fetal hemoglobin.

Increases in fetal hemoglobin have been identified after birth in several clinical settings associated with stressed or malignant erythropoiesis. To better understand the relationship between the expression of this fetal protein and growth, donated human erythroid progenitor cells were cultured in the presence of erythropoietin (EPO) plus the growth-modifying cytokine stem cell factor (SCF), and several growth-related signaling pathways were interrogated. Only the MEK1/2 inhibitor (PD98059) demonstrated significant effects on fetal hemoglobin. In the absence of PD98059, levels of fetal hemoglobin averaged 27.4% +/- 7.9% in EPO+SCF compared with 1.26% +/- 1.7% in EPO alone (P =.02). A linear dose response in levels of fetal hemoglobin to PD98059 was detected (0.16 microM = 27.13%, 0.8 microM = 19.6%, 4 microM = 12.2%, 20 microM = 1.54%). Western blot analyses revealed that SCF was required for phosphorylation of MEK and p44MAPK in this setting, and quantitative polymerase chain reaction demonstrated a significant increase in gamma-globin mRNA. Particular perturbations of growth-related signaling may also function to activate tissue-specific genes normally expressed during fetal development. This concept may be relevant for the development of new treatment rationales for beta hemoglobinopathies.

[1]  M. Gladwin,et al.  Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. , 2003, The Journal of clinical investigation.

[2]  Jeffery L. Miller,et al.  Fetal hemoglobin modulation during human erythropoiesis: stem cell factor has "late" effects related to the expression pattern of CD117. , 2003, Blood.

[3]  H. Soreq,et al.  Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements. , 2002, European journal of biochemistry.

[4]  Jeffery L. Miller,et al.  Fetal and adult hemoglobin production during adult erythropoiesis: coordinate expression correlates with cell proliferation. , 2002, Blood.

[5]  A. Verma,et al.  Activation of the p38 Mitogen-activated Protein Kinase Mediates the Suppressive Effects of Type I Interferons and Transforming Growth Factor-β on Normal Hematopoiesis* , 2002, The Journal of Biological Chemistry.

[6]  Jeffery L. Miller.  Hemoglobin switching and modulation: genes, cells, and signals , 2002, Current opinion in hematology.

[7]  L. Mahadevan,et al.  Transcription: MAPK-regulated transcription: a continuously variable gene switch? , 2002, Nature Reviews Molecular Cell Biology.

[8]  T. Chin,et al.  Antiproliferative effect of nitric oxide on rat glomerular mesangial cells via inhibition of mitogen-activated protein kinase. , 2001, European journal of biochemistry.

[9]  H. Lodish,et al.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.

[10]  M. Ratajczak,et al.  Biological significance of MAPK, AKT and JAK‐STAT protein activation by various erythropoietic factors in normal human early erythroid cells , 2001, British journal of haematology.

[11]  Jianqi Yang,et al.  Sodium Butyrate Induces Transcription from the Gαi2Gene Promoter through Multiple Sp1 Sites in the Promoter and by Activating the MEK-ERK Signal Transduction Pathway* , 2001, The Journal of Biological Chemistry.

[12]  J. Groopman,et al.  Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. , 2001, Blood.

[13]  A. Schechter,et al.  Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease , 2001, Current opinion in hematology.

[14]  Kavita Shah,et al.  ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation , 2001, Nature Cell Biology.

[15]  M. Cappellini,et al.  Mechanism for fetal globin gene expression: role of the soluble guanylate cyclase-cGMP-dependent protein kinase pathway. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Lavelle,et al.  Effects of hydroxurea, stem cell factor, and erythropoietin in combination on fetal hemoglobin in the baboon. , 2001, Experimental hematology.

[17]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[18]  W. Kolch.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.

[19]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[20]  G. Adler,et al.  TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation , 2000, Oncogene.

[21]  Z. Zhao,et al.  Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways , 2000, British journal of haematology.

[22]  R. Buscà,et al.  Ras mediates the cAMP‐dependent activation of extracellular signal‐regulated kinases (ERKs) in melanocytes , 2000, The EMBO journal.

[23]  C. Peschle,et al.  Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate. , 2000, Blood.

[24]  B. Forget.  Molecular Basis of Hereditary Persistence of Fetal Hemoglobin , 1998, Annals of the New York Academy of Sciences.

[25]  T. Jacks,et al.  Nf1 Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines , 1998, The Journal of experimental medicine.

[26]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[27]  B. Haye,et al.  Activation of Raf-1 and mitogen-activated protein kinases by erythropoietin and inositolphosphate-glycan in normal erythroid progenitor cells: involvement of protein kinase C. , 1997, Cellular signalling.

[28]  M. Freedman,et al.  Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. , 1996, Blood.

[29]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[30]  C. Peschle,et al.  c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid. , 1993, Blood.

[31]  G. Stamatoyannopoulos,et al.  Fetal hemoglobin in acute and chronic states of erythroid expansion. , 1993, Blood.

[32]  D. Williams,et al.  Influence of steel factor on hemoglobin synthesis in sickle cell disease. , 1992, Blood.

[33]  B. Alter,et al.  Adult‘fetal‐like’erythropoiesis characterizes recovery from bone marrow transplantation , 1986, British journal of haematology.

[34]  M. Adinolfi,et al.  Cancer, oncogenes and oncofetal antigens. , 1985, The Quarterly journal of medicine.

[35]  G. Stamatoyannopoulos,et al.  Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of HbF by 5-azacytidine. , 1984, Blood.

[36]  G. Stamatoyannopoulos,et al.  F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F. , 1975, Blood.

[37]  J. Edwards,et al.  Haemoglobin and red cell enzyme changes in juvenile myeloid leukaemia. , 1968, British medical journal.